Axa S.A. Bio Rad Laboratories, Inc. Transaction History

Axa S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $4.74 Million - $5.95 Million	-7,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $3.75 Million - $4.22 Million	6,500 Added 928.57%	7,200 $4.64 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $382,907 - $463,645	700 New	700 $400,000
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $510,680 - $643,450	-1,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $181,772 - $214,240	-400 Reduced 28.57%	1,000 $515,000
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $2.31 Million - $3.4 Million	-6,900 Reduced 83.13%	1,400 $632,000
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $2.66 Million - $3.4 Million	8,300 New	8,300 $2.91 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.